[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO962415L - Metode for nedsettelse av serumkolesterolnivåer med 2,6-dialkyl-4-silylfenoler - Google Patents

Metode for nedsettelse av serumkolesterolnivåer med 2,6-dialkyl-4-silylfenoler

Info

Publication number
NO962415L
NO962415L NO962415A NO962415A NO962415L NO 962415 L NO962415 L NO 962415L NO 962415 A NO962415 A NO 962415A NO 962415 A NO962415 A NO 962415A NO 962415 L NO962415 L NO 962415L
Authority
NO
Norway
Prior art keywords
silylphenols
dialkyl
cholesterol levels
serum cholesterol
lowering serum
Prior art date
Application number
NO962415A
Other languages
English (en)
Other versions
NO962415D0 (no
NO311868B1 (no
Inventor
Simon Jen Tan Mao
Mark Thirston Yates
Roger Alan Parker
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO962415D0 publication Critical patent/NO962415D0/no
Publication of NO962415L publication Critical patent/NO962415L/no
Publication of NO311868B1 publication Critical patent/NO311868B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO19962415A 1993-12-10 1996-06-07 Anvendelse av 2,6-dialkyl-4-silylfenoler for fremstilling av et medikament for nedsettelse av serumkolesterolnivåer NO311868B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16528193A 1993-12-10 1993-12-10
PCT/US1994/012702 WO1995015760A1 (en) 1993-12-10 1994-11-03 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols

Publications (3)

Publication Number Publication Date
NO962415D0 NO962415D0 (no) 1996-06-07
NO962415L true NO962415L (no) 1996-06-07
NO311868B1 NO311868B1 (no) 2002-02-11

Family

ID=22598245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962415A NO311868B1 (no) 1993-12-10 1996-06-07 Anvendelse av 2,6-dialkyl-4-silylfenoler for fremstilling av et medikament for nedsettelse av serumkolesterolnivåer

Country Status (16)

Country Link
EP (3) EP1468692B1 (no)
JP (1) JPH09511222A (no)
CN (1) CN1092517C (no)
AT (2) ATE285238T1 (no)
AU (1) AU681731B2 (no)
CA (1) CA2177968C (no)
DE (2) DE69434198T2 (no)
DK (2) DK1468692T3 (no)
ES (2) ES2263094T3 (no)
HU (1) HU220761B1 (no)
IL (1) IL111905A (no)
NO (1) NO311868B1 (no)
NZ (1) NZ276285A (no)
PT (2) PT732928E (no)
WO (1) WO1995015760A1 (no)
ZA (1) ZA949663B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009370B1 (ru) * 1997-05-14 2007-12-28 Атеродженикс, Инк. Соединение и фармацевтическая композиция для ингибирования экспрессии vcam-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
CA2293461C (en) * 1997-06-24 2004-02-24 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
JP2002506443A (ja) * 1997-06-25 2002-02-26 アベンティス・ファーマスーティカルズ・インコーポレイテッド ２，６−ジ−ｔ−ブチル−４−［（ジメチル−４−メトキシフェニルシリル）メチルオキシ］フェノール及び２，６−ジ−ｔ−ブチル−４−［（ジメチル−２−メトキシフェニルシリル）メチルオキシ］フェノール
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
EA200000087A1 (ru) 1997-07-01 2000-08-28 Атеродженикс, Инк. Повышение эффективности терапии гиперпролиферативных состояний с помощью антиоксиданта
ATE326014T1 (de) * 1998-11-09 2006-06-15 Atherogenics Inc Methode und zusammensetzungen zum vermindern des cholesterolspiegels im plasma
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6821738B2 (en) 1999-01-20 2004-11-23 The Board Of Regents For Oklahoma State University Broad spectrum bio-detection of nerve agents, organophosphates, and other chemical warfare agents
WO2002040021A2 (en) 2000-11-17 2002-05-23 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
WO2003053368A2 (en) 2001-12-19 2003-07-03 Atherogenics, Inc. Chalcone derivatives and their use to treat diseases
WO2004007423A1 (en) 2002-07-12 2004-01-22 Atherogenics, Inc. Novel salt forms of poorly soluble probucol esters and ethers
WO2004108094A2 (en) 2003-06-06 2004-12-16 Atherogenics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
JP2007509054A (ja) * 2003-10-17 2007-04-12 アミリン・ファーマシューティカルズ，インコーポレイテッド 血管健康を促進するシリルフェノール
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
EP2139320A4 (en) 2007-03-26 2010-09-08 Salutria Pharmaceuticals Llc METHODS AND COMPOSITIONS OF PROBUCOL DERIVATIVES FOR THE TREATMENT OF DIABETES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE349046B (no) * 1966-12-23 1972-09-18 C Guevne
FR2230376A1 (en) * 1973-05-24 1974-12-20 Gueyne Jean Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity
FR2308372A2 (fr) * 1975-04-21 1976-11-19 Cortial Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif
US4670421A (en) * 1982-07-12 1987-06-02 American Cyanamid Company Antiatherosclerotic silanes
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
US5155250A (en) * 1990-07-05 1992-10-13 Merrell Dow Pharmaceuticals Inc. 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents
NZ238807A (en) * 1990-07-05 1994-03-25 Merrell Dow Pharma Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions

Also Published As

Publication number Publication date
EP1468693A2 (en) 2004-10-20
WO1995015760A1 (en) 1995-06-15
DE69434720T2 (de) 2007-05-16
DK0732928T3 (da) 2005-04-18
CA2177968A1 (en) 1995-06-15
PT1468692E (pt) 2006-09-29
PT732928E (pt) 2005-03-31
EP0732928A1 (en) 1996-09-25
HU9601590D0 (en) 1996-08-28
IL111905A (en) 2001-04-30
HUT74015A (en) 1996-10-28
EP0732928B1 (en) 2004-12-22
CN1092517C (zh) 2002-10-16
DE69434720D1 (de) 2006-06-01
CN1140995A (zh) 1997-01-22
EP1468692A2 (en) 2004-10-20
AU681731B2 (en) 1997-09-04
NO962415D0 (no) 1996-06-07
ZA949663B (en) 1995-08-15
ES2233937T3 (es) 2005-06-16
EP1468693A3 (en) 2004-11-03
HU220761B1 (hu) 2002-05-28
AU1049995A (en) 1995-06-27
DE69434198D1 (de) 2005-01-27
DE69434198T2 (de) 2005-12-29
ATE285238T1 (de) 2005-01-15
NO311868B1 (no) 2002-02-11
ES2263094T3 (es) 2006-12-01
JPH09511222A (ja) 1997-11-11
NZ276285A (en) 2004-11-26
CA2177968C (en) 2000-03-28
IL111905A0 (en) 1995-03-15
DK1468692T3 (da) 2006-08-28
EP1468692B1 (en) 2006-04-26
ATE324113T1 (de) 2006-05-15
EP1468692A3 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
NO962415D0 (no) Metode for nedsettelse av serumkolesterolnivåer med 2,6-dialkyl-4-silylfenoler
NO179142C (no) 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
DK0605193T3 (da) Anvendelse af benzothiophener til behandling af hypercholesterolæmi
CA2046051A1 (en) 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
ATE181066T1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
FI864618A (fi) Nya 3-oxadiazol- och 3-karboksylsyra- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
ATE128710T1 (de) Naphtoesäure-derivat.
IE880772L (en) Benzoxazines
AU598229B2 (en) Novel indenothiazole derivatives and process for their preparation
EP0335979A4 (en) Thienopyrimidine derivatives
NO960308L (no) Terapeutisk aktive benzoksaziner og benzotioanoner
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
DE69214180D1 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees